- Report
- May 2024
- 194 Pages
Global
From €4770EUR$4,950USD£4,103GBP
- Report
- October 2023
- 178 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1445EUR$1,500USD£1,243GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1445EUR$1,500USD£1,243GBP
- Report
- March 2024
- 267 Pages
Global
From €7661EUR$7,950USD£6,590GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1445EUR$1,500USD£1,243GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1445EUR$1,500USD£1,243GBP
- Report
- May 2019
- 84 Pages
Global
From €6740EUR$6,995USD£5,798GBP
- Report
- February 2022
- 50 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Drug Pipelines
- October 2020
- 93 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Drug Pipelines
- October 2020
- 59 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Drug Pipelines
- July 2020
- 61 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Report
- July 2023
- 73 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- July 2022
- 51 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Report
- June 2022
- 85 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Report
- May 2022
- 43 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- November 2021
- 844 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- April 2024
- 160 Pages
From €5781EUR$5,999USD£4,972GBP
The Neurotrophic Factor market is a subset of the Central Nervous System Drugs market, which focuses on treatments for neurological disorders. Neurotrophic Factors are proteins that promote the growth and survival of neurons, and are used to treat a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Neurotrophic Factors are typically administered through injections, and can be used to replace lost or damaged neurons, or to stimulate the growth of new neurons.
The Neurotrophic Factor market is highly competitive, with a number of companies developing and marketing treatments. Companies in the market include Biogen, Novartis, Merck, and Pfizer. Show Less Read more